Aethlon Medical Inc.
AEMD:NASDAQ
Aethlon Medical Inc. creates affinity biofiltration devices to treat life-threatening diseases. The company's lead therapeutic candidate is the Aethlon Hemopurifier, a first-in-class device that targets the rapid elimination of infectious viruses and cancer-promoting exosomes from the circulatory system of treated individuals.
Streetwise Company Fact Sheet
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
